Search Results

Syngo® Dual Energy is designed to operate with Siemens Dual Source CT scanners. CT images taken at the same time, using two different kV levels, of the same anatomical region of a patient are used. Depending on the region of interest, contrast agents may be used. The differences in the energy dependence of the attenuation coefficient of the different materials provide information about the chemical composition of body materials. The images are combined to visualize and analyze information about anatomical and pathological structures. The functionality of the syngo® Dual Energy has been extended with additional applications.

Syngo® Dual Energy is designed to operate with Siemens Dual Source CT scanners. CT images taken at the same time, using two different kV levels, of the same anatomical region of a patient are used. Depending on the region of interest, contrast agents may be used. The differences in the energy dependence of the attenuation coefficient of the different materials provide information about the chemical composition of body materials. The images are combined to visualize and analyze information about anatomical and pathological structures. The functionality of the syngo® Dual Energy has been extended with additional applications.

The provided text is a 510(k) summary for a medical device called "syngo® Dual Energy with extended functionality". It contains details about the device's classification, contact information, and intended use. However, it does not contain any information regarding acceptance criteria, study design, or performance metrics.

Therefore, I cannot provide the requested information about acceptance criteria or a study proving the device meets them based on the given text.

The document discusses general safety and effectiveness concerns and states that "Risk management is ensured via a hazard analysis, which is used to identify potential hazards. These potential hazards are controlled via software development, verification and validation testing." However, it does not elaborate on specific acceptance criteria or the results of these verification and validation tests.

The listed predicate devices suggest this is a substantial equivalence submission, which typically focuses on demonstrating that a new device is as safe and effective as a legally marketed predicate device, rather than performing a full clinical trial with defined acceptance criteria and performance studies for a novel device.

Ask a specific question about this device